Table 4 Pre-reoperation data of IMHA patients
From: Intractable mechanical hemolytic anemia complicating mitral valve surgery: a case series study
Early IMHA | Late IMHA | Total | |
|---|---|---|---|
Symptoms and signs | |||
Jaundice | 6 (60) | 12 (80) | 18 (72) |
Dark Urine | 8 (80) | 13 (87) | 21 (84) |
Heart failure | 3 (30) | 13 (87) | 16 (64) |
Acute kidney injury | 4 (40) | 7 (47) | 11 (44) |
Hepatomegaly | 3 (30) | 12 (80) | 15 (60) |
Splenomegaly | 3 (30) | 12 (80) | 15 (60) |
Laboratory results | |||
Hb (g/L) | 68 ± 14 | 72 ± 16 | 70 ± 14 |
Cr (μmol/L) | 127 ± 95 | 142 ± 121 | 136 ± 101 |
Tbil (μmol/L) | 41 ± 19 | 89 ± 62 | 72 ± 57 |
Dbil (μmol/L) | 13 ± 7 | 18 ± 8 | 16 ± 7 |
LDH (IU/L) | 1623 ± 1009 | 3263 ± 2462 | 2607 ± 2142 |
Mitral valve echo parameters | |||
Flow rate (m/s) | 2.3 ± 0.6 | 2.6 ± 0.4 | 2.5 ± 0.5 |
Peak pressure (mmHg) | 23.3 ± 11.4 | 27.2 ± 9.3 | 25.6 ± 10.3 |
Regurgitation (1+/2+/3+) | 1/3/6 | 1/10/4 | 2/13/10 |
Pre-op transfusion volume | |||
RBC (U) | 1 (0,2) | 5 (2,8) | 2 (1,7) |
Plasma (ml) | 0 (0, 100) | 100 (0,400) | 0 (0,400) |
Pre-op medication | |||
Beta-blocker | 9 (90) | 13 (87) | 22 (88) |
Iron supplements | 8 (80) | 12 (80) | 20 (80) |
Erythropoietin | 6 (60) | 10 (67) | 16 (64) |